Diagnostic Consulting Network, LLC
Carlsbad, CA Doing business as DCN Diagnostics
- UEI
- HDHMAZK2SZV4
- CAGE
- 51TS7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3193 Lionshead Ave Suite 200, Carlsbad, CA 92010, USA
- Website
- dcndx.com
- Founded
- 2005
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $129,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $129,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Southern California | 75D30123C18191 | $3,378,205 |
Grant awards
Similar vendors
About the company
Diagnostic Consulting Network, LLC, doing business as DCN Diagnostics, is a for-profit limited liability company that has been registered to receive federal government awards since April 10, 2008. The company specializes in the development and manufacturing of rapid diagnostic tests, particularly lateral flow assays (LFAs) for various applications including disease diagnosis and biomarker detection. DCN Diagnostics has established itself as an expert in creating point-of-care (PoC) devices with high sensitivity and specificity, utilizing advanced technologies such as fluorescent labels and custom high-affinity detection reagents. Their expertise extends to developing multiplex test strips integrated into custom-designed cassettes, achieving detection limits at the picogram per milliliter level. The company's capabilities encompass a wide range of diagnostic solutions, from common tests like hCG and Strep A to more complex assays for emerging public health needs.
Through its federal contract awards, DCN Diagnostics has been involved in several significant projects related to diagnostic testing. As a subcontractor to the University of Southern California, the company has worked on developing rapid lateral flow assays for detecting sexually transmitted infections, specifically Neisseria gonorrhoeae and Chlamydia trachomatis. Additionally, DCN has collaborated with UES Inc. on creating functional prototypes and initial stock of lateral flow assay devices to detect creatine in human urine, likely for military or aerospace applications given the involvement of the Air Force. The company has also demonstrated experience in developing antigen detection assays for various infectious diseases, including HIV, Dengue, Influenza, and most recently, SARS-CoV-2. These projects showcase DCN Diagnostics' ability to respond to diverse diagnostic needs across different sectors, from public health to military applications, and highlight their capacity to work on both prime and subcontract levels in federal contracting.
SBA capabilities narrative
DCN Diagnostics supplies services and products for Lateral Flow Test manufacturers. We provide Custom Assay Development and Conjugation Services and other materials and reagents as well. We conduct Education Courses on Lateral Flow Test Technologies.
Quick answers
Is Diagnostic Consulting Network, LLC registered in SAM.gov?
Yes. Diagnostic Consulting Network, LLC's SAM.gov registration is active through September 24, 2027.
How much has Diagnostic Consulting Network, LLC received in federal contracts?
Federal contracts obligated $129,000 to Diagnostic Consulting Network, LLC in fiscal years 2023 through 2027.
What is Diagnostic Consulting Network, LLC's most recent federal award?
Diagnostic Consulting Network, LLC's most recent federal contract award is Lateral flow immunoassay (1232SA26P0225), from Central Program Planning Coordination and Support (ARS), on April 23, 2026.
On GovTribe
See Diagnostic Consulting Network, LLC's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors